Cronos Group Inc (CRON)
$10.29 0.06 (0.59%)
19:59 EDT CRON Stock Quote Delayed 15 Minutes
Previous Close $10.29
Market Cap 1.81B
PE Ratio -
Volume (Avg. Vol.) 3.14M
Day's Range 10.04 - 10.47
52-Week Range 6.50 - 25.10
Dividend & Yield N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
- From InvestorPlace
- From the Web
To be fair, Cronos posted an increase in sales during the second quarter, but its negative cash flow position also rose and some analysts continue questioning the company's position in its home market of Canada.
The best stocks in the pot sector might be the medical marijuana plays. These 3 medical marijuana stocks should have big upside.
Canadian headwinds are holding back Cronos Group stock as the next deregulation phase looms. Still CRON stock is doing better than peers.
Throughout this year, marijuana-related investments like Aurora Cannabis stock took a massive beating. Still, markets work in cycles and with ACB not dropping to new lows, it suggests a possible turnaround is coming with the right catalyst.
CRON stock has suffered in recent days due to growing concern about vaping. But Altria should help CRON weather the storm.
By Thomas Niel
Many risks continue to make Cronos Group stock's valuation mind-boggling. Consider anything but CRON stock for a pot play.
Shares of Canopy Growth stock have been struggling immensely over the last few months. However, CGC has some new momentum.
Although Cronos Group stock has the reputation for being the most stable of the cannabis players, it took a big dive on Monday. The reason why is likely due to serious concerns about the cannabis-based vaporizers, of which Cronos has a vested interest.
CRON stock is off 50% since February, partly because investors see it like other, larger cannabis companies. Here's why Cronos Group stands out.
Throughout the entire legal marijuana industry, a sea of red ink plagues many competitors. However, HEXO has an extremely rich valuation. If the Hexo stock price doesn’t start showing upside momentum, it could be in for some real pain.
Aurora Cannabis stock is drifting lower for a reason, even of most investors are struggling to articulate it as earnings news nears.
By Theodore Kim
CRON stock could continue to show strong revenue growth, making this dip a great buying opportunity in Cronos.
For now, Cronos Group stock remains an extremely pricey marijuana play, despite its recent sharp losses. But in the long term, its backer Altria may mold and shape CRON into a cannabis version of itself.
Cronos Group stock may not be attractive to institutions with ESG concerns. That is because its deal with Altria makes it a sin stock.
There are a ton of pot stocks out there, but only four of them have a realistic opportunity to strike gold in the long run.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!